Your browser doesn't support javascript.
loading
Comparative Effectiveness of Lifestyle Intervention on Fasting Plasma Glucose in Normal Weight Versus Overweight and Obese Adults With Prediabetes.
Salmon, Mandy K; Gordon, Neil F; Constantinou, Demitri; Reid, Kevin S; Wright, Brenda S; Kridl, Terri L; Faircloth, George C.
Afiliación
  • Salmon MK; Medical and Science Office, INTERVENT International, Savannah, Georgia.
  • Gordon NF; Medical and Science Office, INTERVENT International, Savannah, Georgia.
  • Constantinou D; Centre for Exercise Science and Sports Medicine, FIMS Collaborating Center of Sports Medicine, School of Therapeutic Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
  • Reid KS; Medical and Science Office, INTERVENT International, Savannah, Georgia.
  • Wright BS; Medical and Science Office, INTERVENT International, Savannah, Georgia.
  • Kridl TL; Medical and Science Office, INTERVENT International, Savannah, Georgia.
  • Faircloth GC; Medical and Science Office, INTERVENT International, Savannah, Georgia.
Am J Lifestyle Med ; 16(3): 334-341, 2022.
Article en En | MEDLINE | ID: mdl-35706601
ABSTRACT
Background. It is hypothesized that normal weight individuals develop diabetes through different pathophysiological mechanisms and that methods of prevention may differ in the absence of overweight/obesity. In this study, we compared the effect of lifestyle health coaching (LHC) on fasting plasma glucose (FPG) in normal weight, overweight, and obese US adults with prediabetes. Methods. Subjects were 1358 individuals who completed baseline and follow-up evaluations as part of an LHC program (follow-up = ~6 months). Participants were stratified, based on baseline body mass index (BMI), into normal weight (n = 129), overweight (n = 345), and obese (n = 884) cohorts. LHC included counseling, predominantly via telehealth, on exercise and nutrition. Results. BMI decreased (P < .001) in the overweight and obese participants but was unchanged in the normal weight participants. FPG decreased (P < .001) in all 3 cohorts, and the magnitude of decrease did not differ significantly among cohorts. FPG decreased to <5.6 mmol/L in 58.1%, 49.3%, and 41.4% of the normal weight, overweight, and obese participants, respectively. Conclusions. To our knowledge, this study is the first outside of Asia to show that LHC is as effective in managing FPG in normal weight adults with prediabetes versus those who are overweight/obese.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Am J Lifestyle Med Año: 2022 Tipo del documento: Article País de afiliación: Georgia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Am J Lifestyle Med Año: 2022 Tipo del documento: Article País de afiliación: Georgia